Table of Contents

---

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

---

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): April 24, 2003

 

---

 

RESPIRONICS, INC.

(Exact name of Registrant as specified in its charter)

 

Delaware		000-16723		25-1304989
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification Number)

 

1010 Murry Ridge Lane Murrysville, Pennsylvania		15668-8525
(Address of Principal Executive Offices)		(Zip Code)

 

724-387-5200

(Registrant’s telephone number, including area code)

 

---

---

Table of Contents

 

TABLE OF CONTENTS

 

Item 9. REGULATION FD DISCLOSURE.		2
SIGNATURES		3
INDEX TO EXHIBITS		4
EX-99 PRESS RELEASE

---

Table of Contents

 

Item 9. REGULATION FD DISCLOSURE.

 

The following information is furnished pursuant to Item 12, “Disclosure of Results of Operations and Financial Condition.”

 

On April 24, 2003, Respironics Inc. issued a press release announcing its financial results for the three and nine months ended March 31, 2003. A copy of the press release is attached hereto as Exhibit 99.

 

Exhibits

 

99

Press release, dated April 24, 2003, issued by Respironics, Inc.

 

2

---

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated: April 24, 2003

 

3

---

Table of Contents

 

INDEX TO EXHIBITS

 

Exhibit No.		Description
99		Press release, dated April 24, 2003, issued by Respironics, Inc.

 

4